North Carolina Insurance Coverage: What to Expect North Carolina Medicaid, which expanded under the Affordable Care Act in late 2023, does not broadly cover GLP-1 medications for weight loss
Genetic insights should always be interpreted alongside clinical evaluation, not in isolation
3 Consistent with the types of adverse events seen in clinical trials for other incretin-based therapies, the most common adverse events among participants treated with retatrutide (4 mg, 9 mg, 12 mg) were nausea (16.4%, 19.5%, 26.5%, respectively vs
Ive lost 18 pounds, gained a lot of confidence, and Im excited to keep going
For more information, please contact us
Other GLP-/GIP medications, including Wegovy (tirzepatide), Ozempic (tirzepatide), Saxenda (liraglutide), Zepbound (tirzepatide), Mounjaro (tirzepatide), Victoza (liraglutide), Byetta (exenatide), or Bydureon (exenatide)